atenolol has been researched along with Anemia, Hemolytic, Acquired in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubo, T | 1 |
| Kitaoka, H | 1 |
| Terauchi, Y | 1 |
| Tamura, S | 1 |
| Okawa, M | 1 |
| Yamasaki, N | 1 |
| Yabe, T | 1 |
| Doi, YL | 1 |
| Fruergaard, P | 1 |
2 other studies available for atenolol and Anemia, Hemolytic, Acquired
| Article | Year |
|---|---|
Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Aged; Anemia, Hemolytic; Anti-Arrhythmia Agents; Atenolol; Cardiomyopathy, Hypertrophic; Echocardiog | 2010 |
[Hemolytic anemia precipitated by asymptomatic arterial hypertension].
Topics: Adult; Anemia, Hemolytic; Atenolol; Female; Humans; Hypertension | 1988 |